AzTrials
AzTrials

Upper Extremity FractureNCT04764591

Tissue Perfusion for Different Approaches of Brachial Plexus Block

A study testing Lateral sagittal approach and Costoclavicular approach in people with Upper Extremity Fracture and Regional Anesthesia, run by Zonguldak Bulent Ecevit University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To compare the two different approaches of infraclavicular brachial plexus block in forearm, wrist and hand surgery in terms of perfusion index, tissue oxygenation, sensory and motor block onset time and total effect time, first analgesic time, side effects and complications, and duration of block application. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
What is being tested?
Lateral sagittal approach and Costoclavicular approach
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2022to 1 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • patients who undergo elective forearm or hand surgery under infraclavicular brachial plexus block
  • American Society of Anesthesiologists class 1 to 3
  • Ability to consent

Who cannot join

  • History of allergic reaction to local anaesthetics
  • Peripheral neuropathy
  • Renal or hepatic insufficiency
  • Coagulation disorders

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Zonguldak Bülent Ecevit University Medicine Faculty

    Zonguldak, Kozlu, 67600

Other trials in Turkey (Türkiye)

About this study

Official title: Effect of Different Approaches of Infraclavicular Brachial Plexus Block on Tissue Perfusion: A Randomized Trial

To compare the two different approaches of infraclavicular brachial plexus block in forearm, wrist and hand surgery in terms of perfusion index, tissue oxygenation, sensory and motor block onset time and total effect time, first analgesic time, side effects and complications, and duration of block application.

Being tested
Lateral sagittal approach, Costoclavicular approach
Keywords
lateral sagittal approach, costoclavicular approach, block success, perfusion index, brachial plexus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lateral sagittal approachOther

    Lateral sagittal approach for ultrasound guided infraclavicular brachial plexus block

  • Costoclavicular approachOther

    Costoclavicular approach for ultrasound guided infraclavicular brachial plexus block

Study groups in NCT04764591
Study groupRoleWhat they receive
Lateral sagittal approachActive comparatorPatients in this group will be randomized to receive a lateral sagittal approach for Ultrasound Guided Infraclavicular Brachial Plexus Nerve Block .
Receives: Other: Lateral sagittal approach
Costoclavicular approachActive comparatorPatients in this group will be randomized to receive a costoclavicular approach to Ultrasound Guided Infraclavicular Brachial Plexus Nerve Block .
Receives: Other: Costoclavicular approach

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. perfusion index

    the effect of the block on the perfusion index

    Measured: up to motor block scale ≥3

  2. tissue oxygenation

    the effect of the block on the tissue oxygenation

    Measured: up to motor block scale ≥3

Secondary outcomes (4)
  1. motor block onset time

    quality of motor block scale ≥2

    Measured: Assessed 40 minutes after block completion

  2. sensorial block onset time

    quality of sensorial block scale ≥2

    Measured: up to 24 hours

  3. complications

    block related complications such as pneumothorax, vascular injury, local anesthetic systemic toxicity

    Measured: up to 24 hours

  4. duration of block application

    from the needle puncture to the end of the local anesthetic injection

    Measured: during the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2021
  2. Study start1 Jan 2022
  3. Primary completion1 Dec 2022
  4. Study completion1 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04764591
Sponsor's protocol ID
2020/24-10
Status last verified
Feb 2024
First submitted
10 Feb 2021
Last updated
9 Feb 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Baytar C, Koksal BG. Effects of different approaches of infraclavicular brachial plexus block on perfusion index and tissue perfusion. Ann Med. 2025 Dec;57(1):2451765. doi: 10.1080/07853890.2025.2451765. Epub 2025 Jan 11.

    PubMed 39797918

Questions about this trial

What is this clinical trial studying?

A study testing Lateral sagittal approach and Costoclavicular approach in people with Upper Extremity Fracture and Regional Anesthesia, run by Zonguldak Bulent Ecevit University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

perfusion index (time frame: up to motor block scale ≥3). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04764591, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2024; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in